Key Healthcare Financing Events in the Second Half of August: Digital Health, MedTech, and Genomics Startups Secure Significant Investments

This issue of the Blue Book comprises 22 pages and covers the following content:

Great news!!! Starting from this issue, the full text of [VCBeat Blue Book] will be regularly shared with group members in the VCBeat WeChat exchange group. To join the VCBeat WeChat exchange group, scan the QR code to apply.》》》

1. Mobile Fitness App Keep Secures Additional Investment from Tencent in Series C+ Round

Just one month after the disclosure of its Series C funding, on August 17, the fitness app Keep announced for the first time via Tencent Chuangye that it had secured a strategic Series C+ investment from Tencent. The specific amount of financing was not disclosed. Public information shows that Keep is a mobile fitness tool app focused on physical exercise, which also incorporates certain social features, allowing users to interact and discuss with each other. Since its launch in February 2015, Keep has amassed 50 million users and completed multiple rounds of financing.

2. U-Tang Secures Tens of Millions in RMB for Series A+ Round Led by Jinku Capital

U-Tang secured investments from Haoyaoshi Pharmacy and Inno Angels in August 2014.Fundsecured millions of yuan in angel financing. In October of the same year, it obtained tens of millions of yuan in Pre-A round financing from Guohai Innovation Capital. Later, in partnership with Qitian Chuangfu, it secured tens of millions of yuan in Series A financing from Langma Peak Venture Capital in September 2015, and raised tens of millions of yuan in Series A+ financing from Jinku Capital in July 2016.

3. Kangtuo Medical Secures Tens of Millions in Series A Funding to Accelerate R&D in Cutting-Edge Medical Technologies

On August 24, it was reported that Xi’an Kangtuo Medical Technology Co., Ltd. (“Kangtuo Medical”), China’s largest company specializing in neurosurgical internal fixation devices, has disclosed to the investment community that it has completed a Series A financing round worth tens of millions of RMB. The investor was Honghui Capital, which has added another “technological powerhouse” to its medical device investment portfolio. Reportedly, the funds raised in this round will be used for the research and development of new products, the development of medical implant products, and marketing efforts in international markets.

4. Weishi Ophthalmology Completes Series A Financing, Led by CDH Investments

“Wei Shi Ophthalmology”Completed Series A financing, led byCDH InvestmentsThe investment, involving tens of millions of RMB. Weishi Eye Care is a mobile professional platform designed for ophthalmologists. By integrating a patient follow-up system and an optometry module, along with adding message notification features, it provides comprehensive services to ophthalmologists.

Keywords: Weishi Ophthalmology, CDH Investments, ophthalmologist

5. Offline Players Strike Back at Online Rivals: Happy Dental Secures 350 Million Yuan in Series A Funding

On August 23, Happy Dentistry held a press conference at the Staff Home, announcing its recent partnership with HuataiMedicalIndustrial funds, Zhongwei Anjian Venture Capital Fund, and Zhuhai Shiji Equity Investment Fund have formally signed investment cooperation agreements, securing RMB 350 million in financing. It is reported that Happy Dentistry was first established in 2007, starting as a clinic. To date, Happy Dentistry has opened eight dental hospitals and nearly 60 chain dental medical institutions, with over 1,000 medical, nursing, and management staff.

6. Kyee Group and Quyi Network Complete New Funding Rounds, with Total Exceeding RMB 300 Million

On August 25, Kyee Group and Quyi Network jointly completed a new round of financing totaling RMB 313 million.Among them, Kyee Group completed its Series C+ financing round, raising RMB 97 million; Quyi Network completed its Series B+ financing round, securing RMB 216 million. Previously, Kyee Group received investments from SoftBank China Capital, CDH Ventures, Shengshijing Investment, and other institutions, while Quyi Network secured funding from SoftBank China Capital, Honghui Capital, Baidu, and other investors.

7. Transforming Traditional Diabetes Care, Digital Health Company Health2Sync Secures $3 Million in Series A Funding

On August 25, Taiwanese startup Health2Sync announced that it had secured $3 million in Series A financing, led by WI Harper Group, with participation from Cherubic Ventures, iSeed Ventures, and SparkLabs Global Ventures. The new funds will be used to continue product research and development, while also expanding into overseas markets such as Japan, China, and Southeast Asia.

8. Geneseeq Secures 200 Million Yuan in Series A Financing

GenePlus is a company focused on the field of tumor genetic testing. It has independently developed core technologies such as ER-seq, mTBI, and mClone, initially forming a non-invasive, precise, and dynamic ctDNA detection system. The company provides customers with a series of clinical services and products, including precision medication for tumors, efficacy monitoring, postoperative recurrence detection, and early screening. On August 26, GenePlus announced that it had secured RMB 200 million in Series A financing. This round of investment was led by BGI Genomics, with participation from Volcanic Stone Investment, Sinopharm Capital, and others. The funds raised will primarily be used to launch the cfDNA Baseline Project.

9. Huyanbao Secures $1.5 Million in Angel Financing

Eye Care Guardian is an eye-protection app that filters blue light from the LED screens of Android smart devices and provides eye-usage reports and recommendations to safeguard users’ ocular health. On August 25, Eye Care Guardian announced it had secured RMB 1.5 million in angel-round financing from the Dream Chaser Fund, under Innovation Valley. The company plans to use these funds to refine its product and strengthen team building.

10. Quanyu Healthcare Completes RMB 180 Million Series A+ Financing Round

Quanyu Medical is an oncology service provider specializing in precision cloud-based radiotherapy technology. By leveraging the mdaccAutoPlan radiotherapy planning algorithm and focusing on enhancing medical communication, collaboration, and management, the company utilizes advanced tools such as interoperability, big data, and cloud computing to improve survival rates for cancer patients in China and elevate the standard of oncology care. On August 29, Quanyu Medical announced the completion of its RMB 180 million Series A+ financing round, with investors including Zhenghe Cixi Capital and Lian Fund.

↓↓↓

Author: VCBeat. Please credit the WeChat official account when reposting.VBResearch2016

Starting from this issue, the full text of [VCBeat Blue Book] will be regularly shared with members in the VCBeat WeChat discussion group. To join the VCBeat WeChat discussion group, click here【VBR WeChat Group】

【20-Minute Global Digital Health Industry Trend Discovery】

【[VCBeat Research Report: Unlimited Reading]

Interested parties, click here to view